CRISPR/Cas9 Approach for Cystic Fibrosis Treatment – Cystic Fibrosis News Today
Cystic Fibrosis News Today |
CRISPR/Cas9 Approach for Cystic Fibrosis Treatment
Cystic Fibrosis News Today CRISPR/Cas9 is an experimental therapeutic approach for treating cystic fibrosis (CF). The therapy features a novel protein-RNA complex that is designed to address the genetic mutations that cause the disease by editing a patient’s genetics, correcting … |
|
A Deadly Duo: Gene Therapy, Immunotherapy Combination to Treat Glioblastoma
Specialty Pharmacy Times “We hope the implementation of our gene therapy strategy for gliomas, used in combination with immune checkpoint blockade, will eventually provide successful treatment for patients with devastating brain cancer,” said co-senior author Maria Castro, PhD. |
